A randomized double-blind placebo-controlled study to evaluate the efficacy and safety of Cinryze?? (C1 esterase inhibitor [human]) for the treatment of acute antibody-mediated rejection in kidney transplant patients
|Effective start/end date||6/15/15 → 6/14/20|
- SHIRE HUMAN GENETIC THERAPIES, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.